邁瑞醫療(300760.SZ):公司醫學影像領域的產品包括超聲診斷系統、數字X射線成像系統和PACS
格隆匯5月7日丨邁瑞醫療(300760.SZ)在投資者互動平台表示,公司醫學影像領域的產品包括超聲診斷系統、數字X射線成像系統和PACS。在超聲診斷系統領域,為醫院、診所、影像中心等提供覆蓋從超高端到低端的全系列超聲診斷系統,以及逐步細分應用於放射、婦產、介入、急診、麻醉、重症、肝纖等不同臨牀專業的專用解決方案。在數字X射線成像領域,公司為放射科、ICU、急診科提供包括移動式、雙立柱式和懸吊式在內的多種數字化成像解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.